Hyperkalemia Quality Improvement Program (HK-QIP) study

Trial Identifier: D9480L00029
Sponsor: AstraZeneca
Start Date: June 2025
Primary Completion Date: November 2027
Study Completion Date: November 2027
Condition: Heart, Blood & Circulatory - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
CN Beijing, CN, 100029
CN Benxi, CN, 117000
CN Changchun, CN, 130041
CN Changsha, CN, 410013
CN Changsha, CN, 410008
CN Changsha, CN, 410300
CN Chengdu, CN, 610031
CN Chengdu, CN, 610041
CN Chengdu, CN, 610078
CN Chongqing, CN, 400042
CN Dalian, CN, 116023
CN Fuyang, CN, 236600
CN fuzhou, CN, 350005
CN Fuzhou, CN, 350031
CN Gejiu, CN, 661099
CN Guangzhou, CN, 510280
CN Guangzhou, CN, 510530
CN Guiyang, CN, 510630
CN Haikou, CN, 570311
CN Hangzhou, CN, 310006
CN Hefei, CN, 230001
CN Hohhot, CN, 10050
CN Jinan, CN, 250021
CN Jinan, CN, 250012
CN Kunming, CN, 650101
CN Kunming, CN, 650021
CN Lanzhou, CN, 730030
CN Nanchang, CN, 330006
CN Nanning, CN, 530021
CN Nantong, CN, 226001
CN Ningbo, CN, 315010
CN Pingdingshan, CN, 467000
CN Qiqihar, CN, 161000
CN shanghai, CN, 200025
CN Shanghai, CN, 200032
CN Shanghai, CN, 200233
CN Shenyang, CN, 110001
CN Shijiazhuang, CN, 50051
CN Taiyuan, CN, 030001
CN Tianjin, CN, 300192
CN Urumchi, CN, 830054
CN Wuhan, CN, 430022
CN Wuhu, CN, 241000
CN Wuxi, CN, 214062
CN Xi'an, CN, 710061
CN Xining, CN, 810001
CN Xinxiang, CN, 453100
CN Yinchuan, CN, 750004
CN Zhengzhou, CN, 450003